Translating Innovation to Clinic: End‐to‐End Bioprocess Development and cGMP Manufacturing of N332‐GT5 HIV Vaccine Candidate for First‐In‐Human Trials (HVTN144)

Sammaiah Pallerla, Shaunak D. Uplekar, Ferenc Boldog, James C. Paulson, Sabyasachi Baboo, John R. Yates III, Wen‐Hsin Lee, Gabriel Ozorowski, Joel D. Allen, Max Crispin, Chris Cottrell, Andrew B. Ward, Varsha Sitaraman, Tim Broderick, Amber Costakes, Nikolette McCombs, Derek Ryan, Leslie Wolfe, Daniel Craig, Kristen Syvertsen, Albert E. Price, Jon M. Steichen, William R. Schief
Biotechnology and Bioengineering · Wiley · 2026-10-21 · DOI: 10.1002/bit.70409

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles